Market Access News | pharmaphorum

News

FDA clears Nuvation's first product Ibtrozi, for lung cancer

Nuvation is set to launch its first commercial product after the FDA approved its ROS1 inhibitor Ibtrozi as a treatment for ROS1-positive lung cancer.

News

Concerns rise over ACIP's new membership

RFK Jr names eight members of the CDC's vaccine panel, some known for contrarian views on immunisation, after ousting all 17 of their predecessors.

News

UK follows through on doubling of statutory scheme rate

UK pharma firms have reacted angrily to the news that the government has doubled the statutory scheme rebate on the sales of newer drugs to the NHS.

News

Makary, Prasad set out their vision for the FDA

Top FDA officials have spelled out their strategic priorities in the coming years, including the use of AI to "increase efficiency."

News

Beyfortus now has a direct rival after FDA OK for Enflonsia

MSD could soon enter the US market for drugs used to protect infants from RSV infections, setting up a rivalry with AstraZeneca/Sanofi's Beyfortus.

News

Dismay as RFK Jr ousts CDC vaccine advisors

RFK Jr has removed all 17 members of the CDC's vaccine advisory committee in a move that some fear could lead to restrictions on immunisation access.

FDA clears Nuvation's first product Ibtrozi, for lung cancer

Concerns rise over ACIP's new membership

UK follows through on doubling of statutory scheme rate

Makary, Prasad set out their vision for the FDA

Beyfortus now has a direct rival after FDA OK for Enflonsia

Dismay as RFK Jr ousts CDC vaccine advisors

Novo sues Lilly over 'misleading' GLP-1 ad campaigning

Discover a new era of healthcare panel engagement: Grounded ...

News

Editor's Picks